glp 1 trial The Big of a GLP-1 drug (Wegovy) to Reduce Major Cardiovascular Events Real-World Use of GLP-1s Yields
Description
Beyond weight loss, many patients experience other metabolic improvements, such as better blood pressure, improved cholesterol levels, and a reduced risk of developing type 2 diabetes
But GLP-1 microdosing also comes with some risks to consider
Draw the same number of units from both concentrations and you have just doubled your dose
However, measurable weight loss on the scale typically becomes apparent after 46 weeks of treatment
